Cited by 1,709Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacySynthesis of β-Lactam Compounds

The DOI matches its Crossref record; 462 of the 464 references it cites were found in a registry or an index.

Three Decades of β-Lactamase Inhibitors

Open access

Drawz, Sarah M., Bonomo, Robert A.·2010·Clinical Microbiology Reviews

Open this paper in CoChat — free account

Abstract

Since the introduction of penicillin, beta-lactam antibiotics have been the antimicrobial agents of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened by bacterial beta-lactamases. beta-Lactamases are now responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. In order to overcome beta-lactamase-mediated resistance, beta-lactamase inhibitors (clavulanate, sulbactam, and tazobactam) were introduced into clinical practice. These inhibitors greatly enhance the efficacy of their partner beta-lactams (amoxicillin, ampicillin, piperacillin, and ticarcillin) in the treatment of serious Enterobacteriaceae and penicillin-resistant staphylococcal infections. However, selective pressure from excess antibiotic use accelerated the emergence of resistance to beta-lactam-beta-lactamase inhibitor combinations. Furthermore, the prevalence of clinically relevant beta-lactamases from other classes that are resistant to inhibition is rapidly increasing. There is an urgent need for effective inhibitors that can restore the activity of beta-lactams. Here, we review the catalytic mechanisms of each beta-lactamase class. We then discuss approaches for circumventing beta-lactamase-mediated resistance, including properties and characteristics of mechanism-based inactivators. We next highlight the mechanisms of action and salient clinical and microbiological features of beta-lactamase inhibitors. We also emphasize their therapeutic applications. We close by focusing on novel compounds and the chemical features of these agents that may contribute to a "second generation" of inhibitors. The goal for the next 3 decades will be to design inhibitors that will be effective for more than a single class of beta-lactamases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.00037-09

Cites

462 of 462 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495
Self-citation
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,646
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,609
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,485
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,328
AmpC β-Lactamases
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,277
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,068
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,619
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,542

Show all 464 references

Research works printed but not linked: 14

Danel, F., M. G. Page, and D. M. Livermore. 2007. Class D β-lactamases, p. 163-194. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Dubus, A., P. Ledent, J. Lamotte-Brasseur, and J. M. Frere. 1996. The roles of residues Tyr150, Glu272, and His314 in class C β-lactamases. Proteins25:473-485.
Foulds, G., W. E. Barth, J. R. Bianchine, A. R. English, D. Girard, S. L. Hayes, M. O'Brien, and P. Somani. 1980. Pharmacokinetics of CP-45.899 and pro-drug CP-47.904 in animals and humans, p. 353-356. In J. D. Nelson and C. Grassi (ed.), Current chemotherapy and infectious disease. American Society for Microbiology, Washington DC.
Galleni, M., and J. M. Frere. 2007. Kinetics of β-lactamases and pencillin-binding proteins, p. 195-213. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
F1-310. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-333a. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Livermore, D. M., M. Akova, P. J. Wu, and Y. J. Yang. 1989. Clavulanate and β-lactamase induction. J. Antimicrob. Chemother.24(Suppl. B):23-33.
A1-006. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. 2009
Meroueh, S., J. Cha, and S. Mobashery. 2007. Inhibition of class A β-lactamases, p. 101-114. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washingtion, DC.
Page, M. G. 2007. Resistance mediated by penicllin-binding proteins, p. 81-99. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for Inhibition. ASM Press, Washington, DC.
F1-311. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-0882. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Slocombe, B., A. S. Beale, R. J. Boon, K. E. Griffin, P. J. Masters, R. Sutherland, and A. R. White. 1984. Antibacterial activity in vitro and in vivo of amoxicillin in the presence of clavulanic acid, p. 29-49. InProgress and perspectives on β-lactamase inhibition: a review of Augmentin. Custom Communications: Postgraduate Medicine, New York, NY.

Sorted by citations

Items 601–700 of 1,001

Biology and applications of co-produced, synergistic antimicrobials from environmental bacteria
Meyer, K. J., & Nodwell, J. R. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00952-6 · Cited by 27
Not recommended fixed-dose antibiotic combinations in low- and middle-income countries – the example of Tanzania
Vliegenthart-Jongbloed, K. J., & Jacobs, J. A. (2023) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-023-01238-8 · Cited by 27
Assay for drug discovery: Synthesis and testing of nitrocefin analogues for use as β-lactamase substrates
Ghavami, A., Labbé, G., Brem, J., Goodfellow, V. J., Marrone, L., Tanner, C. A., King, D. T., Lam, M., Strynadka, N. C. J., Pillai, D. R., et al. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.06.032 · Cited by 27
Crystal Structure of a Preacylation Complex of the β-Lactamase Inhibitor Sulbactam Bound to a Sulfenamide Bond-Containing Thiol-β-lactamase
Rodkey, E. A., Drawz, S. M., Sampson, J. M., Bethel, C. R., Bonomo, R. A., & van den Akker, F. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3073676 · Cited by 26
Self-citation
Detection and characterization of multidrug resistance and extended-spectrum-beta-lactamase-producing (ESBLS) Pseudomonas aeruginosa isolates in teaching hospital
Tavajjohi, Z., Moniri, R., & Khorshidi, A. (2011) · African Journal of Microbiology Research · doi:10.5897/ajmr11.260 · Cited by 27
Inhibiting the VIM-2 Metallo-β-Lactamase by Graphene Oxide and Carbon Nanotubes
Huang, P. J., Pautler, R., Shanmugaraj, J., Labbé, G., & Liu, J. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b01954 · Cited by 27
Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N 132 G in the Conserved SDN Motif
Ourghanlian, C., Soroka, D., & Arthur, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02510-16 · Cited by 27
Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options
Aslan, A. T., & Akova, M. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1693258 · Cited by 27
Synthesis of piperacillin with low impurity content using a new three-feed membrane dispersion microreactor
Xie, Y., Huang, G., Wang, Y., Yan, Z., Wang, X., Huang, J., Gao, M., Fei, W., & Luo, G. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.124178 · Cited by 27
Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria
Otsuka, Y. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00842 · Cited by 27
Structure, function, and evolution of metallo-β-lactamases from the B3 subgroup—emerging targets to combat antibiotic resistance
Krco, S., Davis, S. J., Joshi, P., Wilson, L. A., Pedroso, M. M., Douw, A., Schofield, C. J., Hugenholtz, P., Schenk, G., & Morris, M. T. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1196073 · Cited by 26
GRY79 encoding a putative metallo-β-lactamase-trihelix chimera is involved in chloroplast development at early seedling stage of rice
Wan, C., Li, C., Ma, X., Wang, Y., Sun, C., Huang, R., Zhong, P., Gao, Z., Chen, D., Xu, Z., et al. (2015) · Plant Cell Reports · doi:10.1007/s00299-015-1792-y · Cited by 26
Using Fragment-Based Approaches to Discover New Antibiotics
Lamoree, B., & Hubbard, R. E. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218773034 · Cited by 26
α-Angelica Lactone in a New Role: Facile Access to N-Aryl Tetrahydroisoquinolinones and Isoindolinones via Organocatalytic α-CH2 Oxygenation
Thatikonda, T., Deepake, S. K., & Das, U. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b00224 · Cited by 26
Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo‐β‐Lactamases
Chen, A. Y., Thomas, P. W., Cheng, Z., Xu, N., Tierney, D. L., Crowder, M. W., Fast, W. L., & Cohen, S. M. (2019) · ChemMedChem · doi:10.1002/cmdc.201900172 · Cited by 26
Beta-lactam antibiotics
Barreiro, C., Martínez-Cámara, S., García‐Estrada, C., de la Torre, M., & Barredo, J. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95388-7.00001-2 · Cited by 26
Inhibitors of the aminoglycoside 6′-N-acetyltransferase type Ib [AAC(6′)-Ib] identified by in silico molecular docking
Lin, D. L., Tran, T., Adams, C., Alam, J. Y., Herron, S. R., & Tolmasky, M. E. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.016 · Cited by 26
Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature
Cai, Z., Yang, W., He, Y., Chen, Q., Wang, S., Luo, X., & Wang, X. (2016) · Drug Safety - Case Reports · doi:10.1007/s40800-016-0025-9 · Cited by 26
Bio-Prospecting for Broad Spectrum Antibiotic Producing Actinomycetes Isolated from Virgin Soils in Kericho County, Kenya
Rotich, M. C., Magiri, E. N., Bii, C. C., & Maina, N. W. (2017) · Advances in Microbiology · doi:10.4236/aim.2017.71005 · Cited by 26
Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq
Reem F Polse, S. Y. Y. (2016) · Journal of Microbiology and Infectious Diseases · doi:10.5799/jmid.328863 · Cited by 26
Incidence and molecular characterization of the extended spectrum beta lactamase-producing Escherichia coli isolated from urinary tract infections in Eastern Saudi Arabia
Mashwal, F. A., Safi, S. H. E., George, S. K., Adam, A. A. M., & Jebakumar, A. Z. (2017) · Saudi Medical Journal · doi:10.15537/smj.2017.8.18578 · Cited by 26
What's That Resistance Mechanism? Understanding Genetic Determinants of Gram-Negative Bacterial Resistance
Bello, A., & Dingle, T. C. (2018) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2018.10.001 · Cited by 29
Significant publications on infectious diseases pharmacotherapy in 2015
Babic, J. T., Sofjan, A. K., Babin, M., Echevarria, K. L., Ikwuagwu, J. O., Lam, W.-Y. M., Aitken, S. L., & Perez, K. K. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160090 · Cited by 26
Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli
Rodríguez-Villodres, Á., Gil-Marqués, M. L., Álvarez‐Marín, R., Bonnin, R. A., Pachón-Ibáñez, M. E., Aguilar‐Guisado, M., Naas, T., Aznar, J., Pachón, J., Lepe, J. A., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz393 · Cited by 26
The macromolecular neutron diffractometer at the spallation neutron source
Coates, L., & Sullivan, B. (2020) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.11.020 · Cited by 26
Discovery of the Novel Inhibitor Against New Delhi Metallo-β-Lactamase Based on Virtual Screening and Molecular Modelling
Wang, X., Yang, Y., Gao, Y., & Niu, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103567 · Cited by 26
Ceftazidime–Avibactam Resistance Mutations V240G, D179Y, and D179Y/T243M in KPC-3 β-Lactamase Do Not Alter Cefpodoxime–ETX1317 Susceptibility
Shapiro, A. B., Moussa, S. H., Carter, N., Gao, N., & Miller, A. A. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00575 · Cited by 26
Single-molecule theory of enzymatic inhibition predicts the emergence of inhibitor-activator dualityPreprint
Robin, T., Reuveni, S., & Urbakh, M. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1701.04315 · Cited by 33
Antibiotic potentiators as a promising strategy for combating antibiotic resistance
Joseph, J., Boby, S., Mooyottu, S., & Muyyarikkandy, M. S. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00112-4 · Cited by 31
Mechanisms of Carbapenem Resistance in K.pneumoniae and E. coli from Bloodstream Infections in India
Sharma, A., & Bakthavatchalam, Y. D. (2016) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000293 · Cited by 25
Insights into an evolutionary strategy leading to antibiotic resistance
Hou, C.-F. D., Liu, J., Collyer, C. A., Mitić, N., Pedroso, M. M., Schenk, G., & Ollis, D. L. (2017) · Scientific Reports · doi:10.1038/srep40357 · Cited by 25
Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition
Elings, W., Tassoni, R., van der Schoot, S. A., Luu, W., Kynast, J. P., Dai, L., Blok, A. J., Timmer, M., Florea, B. I., Pannu, N. S., et al. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00556 · Cited by 25
Inhibitory effect of soy saponins on the activity of β-lactamases, including New Delhi metallo-β-lactamase 1
Horie, H., Chiba, A., & Wada, S. (2018) · Journal of Food Science and Technology · doi:10.1007/s13197-018-3091-4 · Cited by 25
Antibiotics: mechanisms of action and modern challenges
Upmanyu, N., & Malviya, V. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819001-2.00018-8 · Cited by 31
Physicochemical and Structural Parameters Contributing to the Antibacterial Activity and Efflux Susceptibility of Small-Molecule Inhibitors of Escherichia coli
Zahed, S. S. E., French, S., Farha, M. A., Kumar, G., & Brown, E. D. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01925-20 · Cited by 25
2-Mercaptomethyl Thiazolidines (MMTZs) Inhibit All Metallo-β-Lactamase Classes by Maintaining a Conserved Binding Mode
Hinchliffe, P., Moreno, D. M., Rossi, M.-A., Mojica, M. F., Martínez, V. R., Villamil, V., Spellberg, B. J., Drusano, G. L., Banchio, C., Mahler, G., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00194 · Cited by 25
Self-citation
Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase
Pestana-Nobles, R., Aranguren, Y., Sierra, E. G. M., Yosa, J., Galán‐Freyle, N. J., Sepulveda-Montaño, L. X., Kuroda, D. G., & Pacheco‐Londoño, L. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031630 · Cited by 25
Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam
Malla, T. N., Zielinski, K. A., Aldama, L., Bajt, S., Feliz, D., Hayes, B., Hunter, M. S., Kupitz, C. J., Lisova, S., Knoška, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41246-1 · Cited by 24
Strategies for potentiation of ethionamide and folate antagonists againstMycobacterium tuberculosis
Wolff, K., & Nguyen, L. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.87 · Cited by 25
Analysis of Beta-lactamase production and Antibiotics resistance in Staphylococcus aureus strains
Torimiro, N. (2013) · Journal of Infectious Diseases and Immunity · doi:10.5897/jidi2013.0118 · Cited by 25
Evaluation of levels of antibiotic resistance in groundwater-derived E. coli isolates in the Midwest of Ireland and elucidation of potential predictors of resistance
O’Dwyer, J., Hynds, P. D., Pot, M., Adley, C. C., & Ryan, M. P. (2017) · Hydrogeology Journal · doi:10.1007/s10040-017-1546-8 · Cited by 25
Highly variable absorption of clavulanic acid during the day: a population pharmacokinetic analysis
de Velde, F., de Winter, B. C. M., Koch, B. C. P., van Gelder, T., & Mouton, J. W. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx376 · Cited by 25
Pharmacokinetic evaluation of meropenem and vaborbactam for the treatment of urinary tract infection
Burgos, R. M., Biagi, M. J., Rodvold, K. A., & Danziger, L. H. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1511702 · Cited by 25
SHV Hyperproduction as a Mechanism for Piperacillin–Tazobactam Resistance in Extended-Spectrum Cephalosporin-Susceptible Klebsiella pneumoniae
Han, M. S., Park, K. S., Jeon, J. H., Lee, J. K., Lee, J. H., Choi, E. H., & Lee, S. H. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0079 · Cited by 25
Diazabicyclooctane Functionalization for Inhibition of β-Lactamases from Enterobacteria
Bouchet, F., Atze, H., Fonvielle, M., Edoo, Z., Arthur, M., Ethève‐Quelquejeu, M., & Iannazzo, L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02125 · Cited by 25
Novel Penicillin-Type Analogues Bearing a Variable Substituted 2-Azetidinone Ring at Position 6: Synthesis and Biological Evaluation
Rosa, M. D., Vigliottá, G., Palma, G., Saturnino, C., & Soriente, A. (2015) · Molecules · doi:10.3390/molecules201219828 · Cited by 24
CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate
Shen, Z., Ding, B., Bi, Y., Wu, S., Xu, S., Xu, X., Guo, Q., & Wang, M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01848-16 · Cited by 24
Newer β-Lactam/β-Lactamase Inhibitor for Multidrug-Resistant Gram-Negative Infections: Challenges, Implications and Surveillance Strategy for India
Veeraraghavan, B., Pragasam, A. K., Bakthavatchalam, Y. D., Anandan, S., Ramasubramanian, V., Swaminathan, S., Gopalakrishnan, R., Soman, R. N., Abraham, O., Ohri, V. C., et al. (2018) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_18_326 · Cited by 24
Structural analysis of proteins using X-ray diffraction technique
Gawas, U. B., Mandrekar, V. K., & Majik, M. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817497-5.00005-7 · Cited by 24
Characterization of phenotypic and genotypic traits of carbapenem-resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia
El‐Badawy, M. F., Abdelwahab, S. F., Alghamdi, S. A., & Shohayeb, M. M. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s206691 · Cited by 24
Incidence, Antibiotic Susceptibility and Characterization of Vibrio parahaemolyticus Isolated from Seafood in Selangor, Malaysia
Venggadasamy, V., Loh, T. H., Law, J. W., Ser, H., Letchumanan, V., & Pusparajah, P. (2021) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000233 · Cited by 24
Target‐Based Whole‐Cell Screening by 1H NMR Spectroscopy
Ma, J., Cao, Q., McLeod, S. M., Ferguson, K., Gao, N., Breeze, A. L., & Hu, J. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410701 · Cited by 24
Importance of Position 170 in the Inhibition of GES-Type β-Lactamases by Clavulanic Acid
Frase, H., Tóth, M., Champion, M. M., Antunes, N. T., & Vakulenko, S. B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01292-10 · Cited by 24
Expression of blaA Underlies Unexpected Ampicillin-Induced Cell Lysis of Shewanella oneidensis
Yin, J., Sun, L., Dong, Y., Chi, X., Zhu, W., Qi, S., & Gao, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060460 · Cited by 24
The Inhibition of Extended Spectrum β-Lactamases: Hits and Leads
Farina, D. S. F., Spyrakis, F., Venturelli, A., Cross, S., Tondi, D., & Costi, M. P. (2014) · Current Medicinal Chemistry · doi:10.2174/09298673113206660323 · Cited by 24
A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections
Xin, X.-J., Jian, L., Xia, X., Jia, B., Huang, W., Chong-zhi, L., Wang, C., Zhou, L., Sun, X., Tang, X., et al. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-38 · Cited by 24
Quality of antimicrobial products used in white leg shrimp ( Litopenaeus vannamei ) aquaculture in Northern Vietnam
Tran, K. C., Tran, M. P., Phan, T. V., & Dalsgaard, A. (2017) · Aquaculture · doi:10.1016/j.aquaculture.2017.09.038 · Cited by 24
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7
Zhang, W., Yang, T. K., Pan, X.-Y., Liu, X., Lin, H., Gao, Z., Yang, C., & Cui, Y. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.002 · Cited by 24
QSRR modeling for the chromatographic retention behavior of some β-lactam antibiotics using forward and firefly variable selection algorithms coupled with multiple linear regression
Fouad, M. A., Tolba, E. H., El‐Shal, M. A., & Kerdawy, A. M. E. (2018) · Journal of Chromatography A · doi:10.1016/j.chroma.2018.03.042 · Cited by 24
Aminocarboxylic acids related to aspergillomarasmine A (AMA) and ethylenediamine- N , N ′-disuccinic acid (EDDS) are strong zinc-binders and inhibitors of the metallo-beta-lactamase NDM-1
Tehrani, K. H. M. E., Fu, H., Brüchle, N. C., Mashayekhi, V., Luján, A. P., van Haren, M. J., Poelarends, G. J., & Martin, N. I. (2020) · Chemical Communications · doi:10.1039/d0cc00356e · Cited by 24
Photodynamic inactivation of bacterial carbapenemases restores bacterial carbapenem susceptibility and enhances carbapenem antibiotic effectiveness
Feng, Y., Palanisami, A., Ashraf, S., Bhayana, B., & Hasan, T. G. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.101693 · Cited by 24
In169, A New Class 1 Integron that Encoded blaIMP-18 in a Multidrug-Resistant Pseudomonas aeruginosa Isolate from Mexico
Sánchez-Martinez, G., Garza–Ramos, U., Reyna-Flores, F., Gaytán‐Martínez, J., Lorenzo-Bautista, I. G., & Silva-Sánchez, J. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.05.006 · Cited by 24
Editorial Commentary: Bloodstream Infection Caused by Extended-Spectrum β-Lactamase–Producing Gram-Negative Bacteria: How to Define the Best Treatment Regimen?
Pérez, F., & Bonomo, R. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ007 · Cited by 24
Self-citation
Stimulus-responsive biomacromolecule wound dressings for enhanced drug delivery in chronic wound healing: A review
Mottaghitalab, F., & Farokhi, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136496 · Cited by 25
Development of a novel heterologous β-lactam-specific whole-cell biosensor in Bacillus subtilis
Lautenschläger, N., Popp, P. F., & Mascher, T. (2020) · Journal of Biological Engineering · doi:10.1186/s13036-020-00243-4 · Cited by 23
Evaluation of The Antioxidant, Antimicrobial, and Anticancer Activities of Dicliptera bupleuroides Isolated Compounds Using In Vitro and In Silico Studies
Akbar, S., Ishtiaq, S., Jahangir, M., Elhady, S. S., Bogari, H. A., Alahdal, A. M., Ashour, M. L., & Youssef, F. S. (2021) · Molecules · doi:10.3390/molecules26237196 · Cited by 23
Recommendations to Synthetize Old and New β-Lactamases Inhibitors: A Review to Encourage Further Production
Alfei, S., & Zuccari, G. (2022) · Pharmaceuticals · doi:10.3390/ph15030384 · Cited by 23
Studies on enmetazobactam clarify mechanisms of widely used β-lactamase inhibitors
Lang, P. A., Raj, R., Tumber, A., Lohans, C. T., Rabe, P., Robinson, C. V., Brem, J., & Schofield, C. J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117310119 · Cited by 24
Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs
Hwang, J., Barman, S., Gao, R., Yang, X., O’Malley, A., Nagarkatti, P. S., Nagarkatti, M., Chruszcz, M., & Tang, C. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301764 · Cited by 23
Carbapenem-Resistant Enterobacteriaceae in Urinary Tract Infections: From Biological Insights to Emerging Therapeutic Alternatives
Bologna, E., Licari, L. C., Manfredi, C., Ditonno, F., Cirillo, L., Fusco, G. M., Abate, M., Passaro, F., Mauro, E. D., Crocetto, F., et al. (2024) · Medicina · doi:10.3390/medicina60020214 · Cited by 27
A kinked antimicrobial peptide from Bombina maxima. I. Three-dimensional structure determined by NMR in membrane-mimicking environments
Tőke, O., Bánóczi, Z., Kiraly, P., Heinzmann, R., Bürck, J., Ulrich, A. S., & Hudecz, F. (2011) · European Biophysics Journal · doi:10.1007/s00249-010-0657-0 · Cited by 23
Covalent docking of selected boron-based serine beta-lactamase inhibitors
Sgrignani, J., Novati, B., Colombo, G., & Grazioso, G. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9834-7 · Cited by 23
Structural and biochemical characterization of VIM ‐26 shows that Leu224 has implications for the substrate specificity of VIM metallo‐β‐lactamases
Leiros, H. S., Edvardsen, K. S. W., Bjerga, G. E. K., & Samuelsen, Ø. (2015) · FEBS Journal · doi:10.1111/febs.13200 · Cited by 23
13 C-Carbamylation as a mechanistic probe for the inhibition of class D β-lactamases by avibactam and halide ions
Lohans, C. T., Wang, D. Y., Jorgensen, C., Cahill, S. T., Clifton, I. J., McDonough, M. A., Oswin, H. P., SPENCER, J. M., Domene, C., Claridge, T. D. W., et al. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob01514c · Cited by 23
What the Clinical Microbiologist Should Know About Pharmacokinetics/Pharmacodynamics in the Era of Emerging Multidrug Resistance
Abodakpi, H., Wanger, A. R., & Tam, V. H. (2019) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2019.05.006 · Cited by 23
Structural Insight into the Mechanism of Inhibitor Resistance in CTX-M-199, a CTX-M-64 Variant Carrying the S130T Substitution
Cheng, Q., Xu, C., Chai, J., Zhang, R., Chan, E. W., & Chen, S. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00345 · Cited by 23
Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases
Li, J., Gao, H., Zhai, L., Sun, L.-Y., Chen, C., Chigan, J., Ding, H., & Yang, K. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116128 · Cited by 23
Aspergillomarasmine A, an Inhibitor of Bacterial Metallo‐β‐Lactamases Conferring bla NDM and bla VIM Resistance
von Nussbaum, F., & Schiffer, G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407921 · Cited by 23
N-Boc Deprotection and Isolation Method for Water-Soluble Zwitterionic Compounds
Liu, Z., Yasuda, N., Simeone, M., & Reamer, R. A. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo502319z · Cited by 23
The Structural Role of N170 in Substrate‐Assisted Deacylation in KPC‐2 β‐Lactamase
Parwana, D., Gu, J., Chen, S., Bethel, C. R., Marshall, E. K., Hujer, A. M., Bonomo, R. A., & Haider, S. M. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202317315 · Cited by 22
Self-citation
CTX-M-Producing Escherichia coli: History, Molecular Epidemiology and Laboratory Detection
Peirano, G., Endimiani, A., & Pitout, J. D. D. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s553853 · Cited by 22
A novel potent metal-binding NDM-1 inhibitor was identified by fragment virtual, SPR and NMR screening
Guo, H., Cheng, K., Gao, Y., Bai, W., Wu, C., He, W., Li, C., & Li, Z. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115437 · Cited by 22
Fabrication of CDs hybrid MIL-68(In) derived In2O3In2S3 hollow tubular heterojunction and their exceptional self-powered PEC aptasensing properties for ampicillin detecting
Yan, T., Feng, Y., Ren, X. Z., Li, J., Lu, Y., Sun, M., Yan, L., Wei, Q. L., & Ju, H. (2021) · Journal of Materiomics · doi:10.1016/j.jmat.2021.01.002 · Cited by 22
Specialized Metabolites from Ribosome Engineered Strains of Streptomyces clavuligerus
Shaikh, A. A., Nothias-Scaglia, L.-F., Srivastava, S. K., Dorrestein, P. C., & Tahlan, K. (2021) · Metabolites · doi:10.3390/metabo11040239 · Cited by 22
An active site loop toggles between conformations to control antibiotic hydrolysis and inhibition potency for CTX-M β-lactamase drug-resistance enzymes
Lu, S., Hu, L., Lin, H., Judge, A., Rivera, P., Palaniappan, M., Sankaran, B., Wang, J., Prasad, B. V. V., & Palzkill, T. G. (2022) · Nature Communications · doi:10.1038/s41467-022-34564-3 · Cited by 22
Mapping the determinants of catalysis and substrate specificity of the antibiotic resistance enzyme CTX-M β-lactamase
Judge, A., Hu, L., Sankaran, B., Riper, J. M. V., Prasad, B. V. V., & Palzkill, T. G. (2023) · Communications Biology · doi:10.1038/s42003-023-04422-z · Cited by 22
Analysis of the Binding Forces Driving the Tight Interactions between β-Lactamase Inhibitory Protein-II (BLIP-II) and Class A β-Lactamases
Brown, N. G., Chow, D., Sankaran, B., Zwart, P. H., Prasad, B. V. V., & Palzkill, T. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.265058 · Cited by 23
A kinetic analysis of the inhibition of FOX-4 -lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic -lactams and carbapenems
Papp‐Wallace, K. M., Mallo, S., Bethel, C. R., Taracila, M. A., Hujer, A. M., Fernandez, A., Gatta, J. A., Smith, K. M., Xu, Y., Page, M. G. P., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt434 · Cited by 22
Self-citation
Analysis of the Structure and Function of FOX-4 Cephamycinase
Lefurgy, S. T., Malashkevich, V. N., Aguilan, J. T., Nieves, E., Mundorff, E. C., Biju, B., Noel, M. A., Toro, R., Baiwir, D., Papp‐Wallace, K. M., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01887-15 · Cited by 22
Self-citation
Crystallographic Snapshots of Class A β-Lactamase Catalysis Reveal Structural Changes That Facilitate β-Lactam Hydrolysis
Pan, X., He, Y., Lei, J., Huang, X., & Zhao, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.764340 · Cited by 22
Highly efficient removal of ceftiofur sodium using a superior hydroxyl group functionalized ionic liquid-modified polymer
Cheng, M., Zhang, X., Shi, Y., Shi, D., Zhu, G., & Fan, J. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.01.223 · Cited by 22
Fate and mitigation of antibiotics and antibiotic resistance genes in microbial fuel cell and coupled systems
Liu, Y., Zhang, J., Cheng, D., Guo, W., Liu, X., Chen, Z., Zhang, Z., & Ngo, H. H. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.173530 · Cited by 21
Current strategies for the treatment of complicated intraabdominal infections
Skrupky, L. P., Pennington, B. R. T., & Mazuski, J. E. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.821109 · Cited by 21
Real-time activity monitoring of New Delhi metallo-β-lactamase-1 in living bacterial cells by UV-Vis spectroscopy
Yang, K., Zhou, Y., Ge, Y., & Zhang, Y. (2017) · Chemical Communications · doi:10.1039/c7cc02774e · Cited by 21
Preparation and Evaluation of the ZnO NP–Ampicillin/Sulbactam Nanoantibiotic: Optimization of Formulation Variables Using RSM Coupled GA Method and Antibacterial Activities
Sharma, N., Singh, V., Pandey, A. K., Mishra, B. N., Kulsoom, M., Dasgupta, N., Khan, S. A., El-Enshasy, H. A., & Haque, S. (2019) · Biomolecules · doi:10.3390/biom9120764 · Cited by 21
Insight into the Dual inhibitory Mechanism of verbascoside targeting serine/threonine phosphatase Stp1 against Staphylococcus aureus
Yang, Y., Wang, X., Gao, Y., Wang, H., & Niu, X. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105628 · Cited by 21
The G132S Mutation Enhances the Resistance of Mycobacterium tuberculosis β-Lactamase against Sulbactam
van Alen, I., Chikunova, A., Safeer, A., Ahmad, M. U. D., Anastassis Perrakis, A., & Ubbink, M. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00168 · Cited by 21
Occurrence of emerging multiresistant pathogens in the production chain of artisanal goat coalho cheese in Brazil
Aragão, B. B., Trajano, S. C., de Oliveira, R. P., Carvalho, M. D. C., de Carvalho, R. G., Juliano, M. A., Pinheiro, J. W., & Mota, R. A. (2022) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2022.101785 · Cited by 21
Beta-Lactamases and Their Classification: An Overview
Akhtar, A., Fatima, N., & Khan, H. M. (2022) · Springer eBooks · doi:10.1007/978-981-16-9097-6_3 · Cited by 21
Discovery of Quercetin and Its Analogs as Potent OXA-48 Beta-Lactamase Inhibitors
Zhang, Y., Chen, C., Cheng, B., Gao, L., Qin, C., Zhang, L., Zhang, X., Wang, J., & Wan, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.926104 · Cited by 21

Authors: Drawz, S. M., & Bonomo, R. A.
Affiliations: Departments of Pathology
United States Department of Veterans Affairs (US)
Corresponding author: Bonomo, Robert A.
ORCID: Bonomo, Robert A.
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2010-01
Volume: 23
Issue: 1
Pages: 160-201
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.00037-09
PMC: PMC2806661
OpenAlex: W1895007034
Cited by: 1,709
References: 464
Citations by year: 2026: 83 · 2025: 100 · 2024: 87 · 2023: 86 · 2022: 106 · 2021: 126 · 2020: 151 · 2019: 130 · 2018: 131 · 2017: 119 · 2016: 120 · 2015: 108 · 2014: 93 · 2013: 88 · 2012: 81
FWCI: 4.26
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (1R01A1063517-01)
National Institute of General Medical Sciences (T32GM007250, T32GM07250)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Physical Sciences › Chemistry › Organic Chemistry › Synthesis of β-Lactam Compounds
Keywords: beta-lactamase inhibitors, beta-lactamase, beta-lactam resistance, clavulanic acid, sulbactam, tazobactam, mechanism-based inactivators, carbapenemase inhibitors, extended-spectrum cephalosporin resistance, Enterobacteriaceae, penicillin-resistant staphylococci
MeSH terms: Bacteria, Bacterial Infections, Bacterial Proteins, beta-Lactamases, Enzyme Inhibitors, Humans, beta-Lactam Resistance, beta-Lactamase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Three Decades of β-Lactamase Inhibitors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks